Connect Education Workshops About Doctor-Patient Communication

Upcoming Workshops

For Breast Cancer

1. Dec13

   Living with Breast Cancer - 46th Annual San Antonio Breast Cancer Symposium
   Part I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
   Tags:

   breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
   Register
2. Jan17

   Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)
   Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
   Tags:

   breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
   Register

For Mantle Cell Lymphoma

1. Dec14

   Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtargeted treatmentstreatment
   Register

Past workshops

For All Cancers

1. Diverse Populations Participating in Decisions About Your Care With Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
   Tags:

   black or african americandoctor-patient communicationhealth care disparitieshealth care professionalslgbtq+treatment
2. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
   Tags:

   biomarkersblack or african americandoctor-patient communicationgenomicshealth care disparitiesside effectstreatmenthealth care professionalslgbtq+
3. Diverse Populations Participating in Decisions about Your Care with Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
   Tags:

   black or african americanhealth care disparitieshealth care professionalslgbtq+treatmentdoctor-patient communication
4. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
   Tags:

   doctor-patient communicationhealth care disparitiesside effectstreatmentcoronavirusgenomicsbiomarkers
5. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
   Tags:

   doctor-patient communication
6. COVID-19, Omicron & Delta Variants, COVID-19 Vaccines & Booster Vaccines: Revised Guidelines for People Living with Cancer and Their Loved Ones
   Tags:

   coronavirusdoctor-patient communication
7. How Health Care Disparities May Influence Your Cancer Treatment & Care
   Tags:

   doctor-patient communicationhealth care disparitiestreatmentblack or african american
8. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
   Tags:

   doctor-patient communicationtreatment
9. Cancer and Flu Shots
   Tags:

   adherencedoctor-patient communicationpost-treatment survivorshiptreatment
10. Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
    Tags:

    caregivingcopingdoctor-patient communicationside effectscare planningtreatment
11. Trends in Oncology and Treatment Planning: What You Need to KnowPart I of Life with Cancer: A Guide to Getting the Best Care
    Tags:

    post-treatment survivorshipside effectstreatmentclinical trialsdoctor-patient communicationimmunotherapytargeted treatments
12. Participating in Decisions about Your CarePart V of Life with Cancer: A Guide to Getting the Best Care
    Tags:

    doctor-patient communicationtreatmentcare planning
13. For Caregivers: Care Coordination for Your Loved One Living with Cancer and Other Health ProblemsPart IV of Life with Cancer: A Guide to Getting the Best Care
    Tags:

    care planningcaregivingdoctor-patient communication
14. Understanding the Costs of Care and Your Health Care CoveragePart III of Life with Cancer: A Guide to Getting the Best Care
    Tags:

    financial assistanceinsurancemedicarecare planningdoctor-patient communicationcoping
15. Managing the Costs of Living with Cancer
    Tags:

    financial assistanceinsurancecopingdoctor-patient communication
16. For Health Care Professionals: Care Coordination for Older Men Living with Cancer
    Tags:

    older adultsdoctor-patient communicationhealth care professionals
17. Communicating with Your Health Care Team After Treatment: Making the Most of Your VisitPart II of The Eighth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
    Tags:

    post-treatment survivorshipdoctor-patient communicationadvocacy
18. The Importance of Communicating with Your Doctor About Follow-Up CarePart I of The Sixth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
    Tags:

    post-treatment survivorshipdoctor-patient communication

For Acute Lymphoblastic Leukemia

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Acute Myeloid Leukemia

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Bladder Cancer

1. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
   Tags:

   bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments
2. For Caregivers: Informative Tips to Cope with Your Loved One’s Bladder CancerPart II of Life with Bladder Cancer
   Tags:

   bladder cancercaregivingdoctor-patient communication
3. Bladder Cancer: Treatment UpdatesPart I of Life with Bladder Cancer
   Tags:

   bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments

For Brain Cancer

1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Breast Cancer

1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities
2. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
   Tags:

   breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques
3. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
   Tags:

   triple negative breast cancerbreast cancercaregivingdoctor-patient communicationholidaysstress

For Chronic Lymphocytic Leukemia

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Chronic Myelogenous Leukemia

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Cutaneous T-Cell Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Diffuse Large B-Cell Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Follicular Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Head and Neck Cancer

1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Hodgkin Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Leukemia

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Lung Cancer

1. Non-Small Cell Lung Cancer: For Caregivers – Practical Tips for CopingPart III of Living with Non-Small Cell Lung Cancer
   Tags:

   lung cancercaregivingcopingdoctor-patient communication
2. Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
   Tags:

   lung cancertreatmentcoronavirusdoctor-patient communicationside effects

For Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Mantle Cell Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Marginal Zone Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Mesothelioma

1. Mesothelioma: Innovative Treatment Options
   Tags:

   mesotheliomatreatmentchemotherapyimmunotherapypersonalized medicinetargeted treatmentsside effectsclinical trialsdoctor-patient communication

For Metastatic Breast Cancer

1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
   Tags:

   breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques

For Multiple Myeloma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Coping with the Stresses of Caregiving When Your Loved One Has Multiple MyelomaPart II of Living with Multiple Myeloma
   Tags:

   multiple myelomacaregivingdoctor-patient communicationtreatment
3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
4. Progress in the Treatment of Multiple Myeloma
   Tags:

   multiple myelomatreatmentbone marrow transplantbone healthclinical trialsdoctor-patient communicationneuropathypainside effects

For Myelodysplastic Syndromes

1. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Myeloproliferative Neoplasms

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Non-Hodgkin Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Ovarian Cancer

1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Peripheral T-Cell Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Prostate Cancer

1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Sarcoma

1. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part I of Highlights from the 2023 American Society of Clinical Oncology Meeting
   Tags:

   brain cancerbreast cancerhead and neck cancerovarian cancerprostate cancersarcomaclinical trialsdoctor-patient communicationhealth care professionalshealth care disparities

For Small Lymphocytic Lymphoma

1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Triple Negative Breast Cancer

1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
   Tags:

   breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques
2. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
   Tags:

   triple negative breast cancerbreast cancercaregivingdoctor-patient communicationholidaysstress